Get the Stockscreener App
413.16
4.41%
-19.04
Humana Inc stock is traded at $413.16, with a volume of 1.33M.
It is down -4.41% in the last 24 hours and up +7.39% over the past month.
Humana is one of the largest private health insurers in the US, and the firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from Medicare, Medicaid, and the military's Tricare program. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
See More
Previous Close:
$432.20
Open:
$432.4
24h Volume:
1.33M
Relative Volume:
0.66
Market Cap:
$49.61B
Revenue:
$137.20B
Net Income/Loss:
$1.15B
P/E Ratio:
44.22
EPS:
9.3439
Net Cash Flow:
$1.27B
1W Performance:
-4.33%
1M Performance:
+7.39%
6M Performance:
+105.80%
1Y Performance:
+54.58%
1-Day Range:
$411.77
$432.40
1-Week Range:
$410.50
$442.99
52-Week Range:
$163.11
$456.50
Humana Inc Stock (HUM) Company Profile
Name
Humana Inc
Sector
Industry
Phone
(502) 580-1000
Address
101 E. MAIN STREET, LOUISVILLE, KY
Compare HUM vs UNH, CVS, ELV, CI
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HUM
Humana Inc
|
413.16 | 49.61B | 137.20B | 1.15B | 1.27B | 9.3439 |
UNH
Unitedhealth Group Inc
|
401.43 | 360.32B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
92.36 | 118.13B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
428.26 | 92.88B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
302.30 | 79.88B | 278.13B | 6.74B | 7.66B | 23.60 |
Humana Inc Stock (HUM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-12-26 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Oct-09-26 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Oct-07-26 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Sep-25-26 | Upgrade | Barclays | Equal Weight → Overweight |
| Aug-05-26 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Jul-30-26 | Upgrade | Evercore ISI | In-line → Outperform |
| Jul-30-26 | Upgrade | Leerink Partners | Market Perform → Outperform |
| Jul-30-26 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-29-26 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-13-26 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| May-20-26 | Upgrade | Deutsche Bank | Hold → Buy |
| Feb-12-26 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-02-26 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Jan-07-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-05-25 | Upgrade | Jefferies | Hold → Buy |
| Oct-14-25 | Initiated | Goldman | Sell |
| Sep-22-25 | Initiated | Evercore ISI | In-line |
| May-01-25 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Nov-06-24 | Upgrade | BofA Securities | Underperform → Neutral |
| Oct-11-24 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Oct-08-24 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-07-24 | Downgrade | Jefferies | Buy → Hold |
| Oct-07-24 | Downgrade | TD Cowen | Buy → Hold |
| Oct-03-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-02-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Oct-02-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Oct-02-24 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| Jun-24-24 | Initiated | Morgan Stanley | Equal-Weight |
| Apr-02-24 | Downgrade | BofA Securities | Buy → Neutral |
| Mar-22-24 | Initiated | Raymond James | Mkt Perform |
| Mar-13-24 | Downgrade | Argus | Buy → Hold |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Jan-26-24 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jan-25-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Dec-12-23 | Upgrade | Argus | Hold → Buy |
| Nov-08-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Jul-07-23 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-23-23 | Downgrade | Argus | Buy → Hold |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-13-22 | Upgrade | Goldman | Neutral → Buy |
| Oct-26-22 | Upgrade | Deutsche Bank | Hold → Buy |
| Sep-20-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-17-22 | Initiated | Loop Capital | Buy |
| May-27-22 | Initiated | Bernstein | Mkt Perform |
| Apr-13-22 | Upgrade | UBS | Neutral → Buy |
| Jan-06-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Nov-04-21 | Reiterated | Barclays | Overweight |
| Nov-04-21 | Reiterated | Credit Suisse | Outperform |
| Nov-04-21 | Reiterated | Morgan Stanley | Overweight |
| Nov-04-21 | Reiterated | Oppenheimer | Outperform |
| Nov-04-21 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-27-21 | Initiated | SVB Leerink | Outperform |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Sep-09-21 | Resumed | Barclays | Overweight |
| Jul-09-21 | Initiated | Seaport Global Securities | Neutral |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Jan-04-21 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Oct-02-20 | Initiated | Bernstein | Mkt Perform |
| Jul-01-20 | Initiated | SVB Leerink | Outperform |
| Jun-16-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jun-05-20 | Initiated | Goldman | Buy |
| Jan-03-20 | Reiterated | JP Morgan | Overweight |
| Oct-18-19 | Initiated | Mizuho | Buy |
| Sep-30-19 | Downgrade | BMO Capital Markets | Outperform → Market Perform |
| Sep-12-19 | Initiated | Deutsche Bank | Hold |
| Aug-12-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Apr-23-19 | Initiated | UBS | Neutral |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Dec-20-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-08-18 | Reiterated | BofA/Merrill | Buy |
| Sep-13-18 | Initiated | Barclays | Overweight |
| Jul-12-18 | Resumed | Morgan Stanley | Overweight |
| Jul-06-18 | Reiterated | Piper Jaffray | Overweight |
| Jun-01-18 | Resumed | Citigroup | Buy |
| Feb-08-18 | Upgrade | Credit Suisse | Neutral → Outperform |
| Feb-08-18 | Reiterated | Leerink Partners | Outperform |
| Jan-12-18 | Upgrade | Jefferies | Hold → Buy |
View All
Humana Inc Stock (HUM) Latest News
A Look at Humana Inc (HUM) After 4.4% Decline -- GF Value $382.9 - GuruFocus
Humana Inc. $HUM Position Lifted by Assenagon Asset Management S.A. - MarketBeat
Humana Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Humana Will Drop 37 PPOs for 2027. If Her Plan Is Discontinued, She Can Get a Medigap Window Without Health Questions Even if Humana Offers Another Advantage Plan - Yahoo Finance
Can UNH's Focus on Special Needs Plans Strengthen Medicare Growth? - Zacks Investment Research
Humana Inc. Stock Grades | HUM - Barron's
Humana Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
What Humana’s BlackRock Deal, Village Medical’s Divestitures Signal For Older Adult Primary Care - Home Health Care News
Humana's CenterWell Expansion Gets a Boost From BlackRock's Capital - Zacks Investment Research
Humana's CenterWell Expansion Gets a Boost From BlackRock's Capital - Yahoo Finance
BlackRock to buy majority stake in Humana’s CenterWell clinics for $2.8 billion - STAT
Humana Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders? - TradingView
Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders? - PR Newswire
Humana taps new partner for $2.8B primary care deal - The Business Journals
Humana taps BlackRock as WCAS replacement in CenterWell deal - Modern Healthcare
Perpetual Ltd Sells 10,384 Shares of Humana Inc. $HUM - MarketBeat
BlackRock Will Manage Humana’s CenterWell Clinics In New $2.8 Billion Partnership - Yahoo Finance
Humana expects major liability reduction on new BlackRock clinic JV (HUM:NYSE) - Seeking Alpha
Humana Announces New Strategic Joint Venture with BlackRock to Manage CenterWell Senior Primary Care Clinics - Yahoo Finance
Humana strikes $2.8 billion BlackRock clinic venture deal - Reuters
Humana forms new clinic joint venture with BlackRock unit - StreetInsider
UnitedHealth Group (UNH) Q3 Earnings and Revenues Top Estimates - Zacks Investment Research
Humana Inc. to Release Third Quarter 2026 Results on November 6, 2026 - Yahoo Finance
Humana leads Managed Care winners in new CMS Star RatingsEvercore - Yahoo Finance
Humana leads Managed Care winners in new CMS Star RatingsEvercore - StreetInsider
Humana (HUM) Gets a Major Ratings Boost. Can Earnings Justify the Valuation? - Yahoo Finance
Humana Inc (HUM.SG) stock price, news, quote and history - Yahoo Finance UK
Strength Seen in Humana (HUM): Can Its 11.6% Jump Turn into More Strength? - Zacks Investment Research
DataMeds AI Stock Rises After Humana Adds Medicaid Coverage for ChemoFx Cancer Test - Benzinga
Humana Hits 95% Four-Star Coverage: What it Means for HUM - Yahoo Finance Australia
Humana Announces Improved CMS Star Ratings with 95 Percent of Medicare Advantage Members in 4-Star or Above Plans for 2027 - Humana
Humana Inc Stock (HUM) Moved Up by 12.68% on Oct 9: Drivers Behind the Movement - TradingKey
UnitedHealth vs. Humana: Which Healthcare Giant Has the Edge? - Zacks Investment Research
UnitedHealth vs. Humana: Which Healthcare Giant Has the Edge? - Yahoo Finance
Humana surges after topping 2027 Medicare star ratings - CNBC
Humana Surges on Medicare Quality Ratings Improvement - Bloomberg.com
S&P 500 Futures Rise in Premarket Trading; Lennar, Humana Lead - Barron's
Humana Says 95% of Medicare Advantage Members in 4-Star Plans for 2027 - WSJ
Humana Inc. (HUM) Stock Forecasts - Yahoo Finance
Humana Inc. (HUM) Stock Forecasts - Yahoo Finance
8,526 Shares of Humana Inc. $HUM Purchased by Vista Investment Partners LLC - MarketBeat
UnitedHealth Gears Up for Q3 Earnings: Should Investors Buy the Stock? - Zacks Investment Research
Humana Inc. Advanced Charts | HUM - Barron's
Humana Inc. Research & Ratings | HUM - Barron's
Report highlights Humana’s $13B impact in Louisville - The Business Journals
Humana Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Humana upgraded at Cantor on Medicare margin and STARS recovery - Seeking Alpha
Humana (NYSE:HUM) Stock Rating Upgraded by Cantor Fitzgerald - MarketBeat
UnitedHealth Q3 Coming Up: Two Questions Investors Can't Ignore - Zacks Investment Research
Humana Inc Stock (HUM) Financials Data
Revenue
Net Income
Cash Flow
EPS
Humana Inc Stock (HUM) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Ventura Joseph C | Chief Legal Officer |
Feb 24 '26 |
Option Exercise |
0.00 |
1,035 |
0 |
17,565 |
| Renaudin George II | President, Insurance |
Feb 24 '26 |
Option Exercise |
0.00 |
1,035 |
0 |
16,494 |
| Felter John-Paul W. | SVP, Chief Accting Off & Cont. |
Feb 24 '26 |
Option Exercise |
0.00 |
165 |
0 |
7,568 |
| Shetty Sanjay K | President, CenterWell |
Feb 23 '26 |
Buy |
185.21 |
810 |
150,016 |
11,657 |
| Dintenfass David | President, Enterprise Growth |
Feb 21 '26 |
Option Exercise |
0.00 |
3,858 |
0 |
15,316 |
| Mehta Japan | Chief Information Officer |
Feb 13 '26 |
Option Exercise |
0.00 |
1,682 |
0 |
8,158 |
| Mellet Celeste | Chief Financial Officer |
Feb 13 '26 |
Option Exercise |
0.00 |
7,763 |
0 |
28,454 |
| Rechtin James A. | President & CEO |
Jan 08 '26 |
Option Exercise |
0.00 |
2,183 |
0 |
29,285 |
| O'Hara Michelle A. | Chief Human Resources Officer |
Jan 01 '26 |
Option Exercise |
0.00 |
2,353 |
0 |
10,634 |
| Mellet Celeste | Chief Financial Officer |
Dec 15 '25 |
Option Exercise |
0.00 |
2,128 |
0 |
29,676 |
1.91%
1.17%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):